Drugs / 18F-JSS20-183A
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 0 | NCT06932809 | May 2025 → Apr 2030 expected | tauopathy | University of Pennsylvania | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | 18F-JSS20-183A | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06932809 ↗ |
| Modality | Diagnostic / imaging agent | “PET scan using new radiotracer 18F-JSS20-183A.” NCT06932809 ↗ |